Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Pietrantonio

Showing results (31-40 of 323) with videos related to

Pageof 33
Sort By:
Annals of Surgical Oncology|September 12, 2022
Relapse of Pseudomyxoma Peritonei After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Pattern of Failure, Clinical Management and OutcomesDario Baratti, Shigeki Kusamura, Marcello Guaglio, et al.
Cancers|January 21, 2023
Liver Transplantation for Hepatic Metastases from Colorectal Cancer: Current Knowledge and Open IssuesMarianna Maspero, Carlo Sposito, Matteo Virdis, et al.
Medical Oncology (Northwood, London, England)|January 25, 2012
Hepatic colorectal cancer metastases showing a distinctive pattern of pathological response after metronomic capecitabine and bevacizumabFilippo Pietrantonio, Pamela Biondani, Alessandro Pellegrinelli, et al.
Clinical Interventions in Aging|January 14, 2015
Bevacizumab treatment in the elderly patient with metastatic colorectal cancerMaria Di Bartolomeo, Claudia Maggi, Francesca Ricchini, et al.
British Journal of Clinical Pharmacology|June 26, 2014
Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil: a meta-analysis of published trialsRoberto Iacovelli, Filippo Pietrantonio, Antonella Palazzo, et al.
Nature Reviews. Clinical Oncology|March 11, 2026
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeuticsJoan Choo, Amalya Sargsyan, Vahe Khachatryan, et al.
Tumori|April 2, 2016
Impact on survival of timing and duration of adjuvant chemotherapy in radically resected gastric cancerMaria Di Bartolomeo, Filippo Pietrantonio, Eliana Rulli, et al.
Nature Reviews. Clinical Oncology|April 3, 2025
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancersMargherita Ambrosini, Paolo Manca, Vincenzo Nasca, et al.
Translational Oncology|June 29, 2012
Bax expression is predictive of favorable clinical outcome in chemonaive advanced gastric cancer patients treated with capecitabine, oxaliplatin, and irinotecan regimenFilippo Pietrantonio, Pamela Biondani, Filippo de Braud, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2015
Early tumour shrinkage as a prognostic factor and surrogate end-point in colorectal cancer: a systematic review and pooled-analysisFausto Petrelli, Filippo Pietrantonio, Chiara Cremolini, et al.
Pageof 33

Showing results (31-40 of 323) with videos related to

Sort By:
Pageof 33
Annals of Surgical Oncology|September 12, 2022
Relapse of Pseudomyxoma Peritonei After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Pattern of Failure, Clinical Management and OutcomesDario Baratti, Shigeki Kusamura, Marcello Guaglio, et al.
Cancers|January 21, 2023
Liver Transplantation for Hepatic Metastases from Colorectal Cancer: Current Knowledge and Open IssuesMarianna Maspero, Carlo Sposito, Matteo Virdis, et al.
Medical Oncology (Northwood, London, England)|January 25, 2012
Hepatic colorectal cancer metastases showing a distinctive pattern of pathological response after metronomic capecitabine and bevacizumabFilippo Pietrantonio, Pamela Biondani, Alessandro Pellegrinelli, et al.
Clinical Interventions in Aging|January 14, 2015
Bevacizumab treatment in the elderly patient with metastatic colorectal cancerMaria Di Bartolomeo, Claudia Maggi, Francesca Ricchini, et al.
British Journal of Clinical Pharmacology|June 26, 2014
Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil: a meta-analysis of published trialsRoberto Iacovelli, Filippo Pietrantonio, Antonella Palazzo, et al.
Nature Reviews. Clinical Oncology|March 11, 2026
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeuticsJoan Choo, Amalya Sargsyan, Vahe Khachatryan, et al.
Tumori|April 2, 2016
Impact on survival of timing and duration of adjuvant chemotherapy in radically resected gastric cancerMaria Di Bartolomeo, Filippo Pietrantonio, Eliana Rulli, et al.
Nature Reviews. Clinical Oncology|April 3, 2025
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancersMargherita Ambrosini, Paolo Manca, Vincenzo Nasca, et al.
Translational Oncology|June 29, 2012
Bax expression is predictive of favorable clinical outcome in chemonaive advanced gastric cancer patients treated with capecitabine, oxaliplatin, and irinotecan regimenFilippo Pietrantonio, Pamela Biondani, Filippo de Braud, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2015
Early tumour shrinkage as a prognostic factor and surrogate end-point in colorectal cancer: a systematic review and pooled-analysisFausto Petrelli, Filippo Pietrantonio, Chiara Cremolini, et al.
Pageof 33